Cargando…
Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR()
The treatment of cystic fibrosis (CF) has been transformed by orally-bioavailable small molecule modulators of the cystic fibrosis transmembrane conductance regulator (CFTR), which restore function to CF mutants. However, CFTR modulators are not available to all people with CF and better modulators...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052731/ https://www.ncbi.nlm.nih.gov/pubmed/31902693 http://dx.doi.org/10.1016/j.jcf.2019.12.009 |
_version_ | 1783502914520612864 |
---|---|
author | Bose, Samuel J. Krainer, Georg Ng, Demi R.S. Schenkel, Mathias Shishido, Hideki Yoon, Jae Seok Haggie, Peter M. Schlierf, Michael Sheppard, David N. Skach, William R. |
author_facet | Bose, Samuel J. Krainer, Georg Ng, Demi R.S. Schenkel, Mathias Shishido, Hideki Yoon, Jae Seok Haggie, Peter M. Schlierf, Michael Sheppard, David N. Skach, William R. |
author_sort | Bose, Samuel J. |
collection | PubMed |
description | The treatment of cystic fibrosis (CF) has been transformed by orally-bioavailable small molecule modulators of the cystic fibrosis transmembrane conductance regulator (CFTR), which restore function to CF mutants. However, CFTR modulators are not available to all people with CF and better modulators are required to prevent disease progression. Here, we review selectively recent advances in CFTR folding, function and pharmacology. We highlight ensemble and single-molecule studies of CFTR folding, which provide new insight into CFTR assembly, its perturbation by CF mutations and rescue by CFTR modulators. We discuss species-dependent differences in the action of the F508del-CFTR mutation on CFTR expression, stability and function, which might influence pharmacological studies of CFTR modulators in CF animal models. Finally, we illuminate the identification of combinations of two CFTR potentiators (termed co-potentiators), which restore therapeutically-relevant levels of CFTR activity to rare CF mutations. Thus, mechanistic studies of CFTR folding, function and pharmacology inform the development of highly effective CFTR modulators. |
format | Online Article Text |
id | pubmed-7052731 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-70527312020-03-09 Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR() Bose, Samuel J. Krainer, Georg Ng, Demi R.S. Schenkel, Mathias Shishido, Hideki Yoon, Jae Seok Haggie, Peter M. Schlierf, Michael Sheppard, David N. Skach, William R. J Cyst Fibros Article The treatment of cystic fibrosis (CF) has been transformed by orally-bioavailable small molecule modulators of the cystic fibrosis transmembrane conductance regulator (CFTR), which restore function to CF mutants. However, CFTR modulators are not available to all people with CF and better modulators are required to prevent disease progression. Here, we review selectively recent advances in CFTR folding, function and pharmacology. We highlight ensemble and single-molecule studies of CFTR folding, which provide new insight into CFTR assembly, its perturbation by CF mutations and rescue by CFTR modulators. We discuss species-dependent differences in the action of the F508del-CFTR mutation on CFTR expression, stability and function, which might influence pharmacological studies of CFTR modulators in CF animal models. Finally, we illuminate the identification of combinations of two CFTR potentiators (termed co-potentiators), which restore therapeutically-relevant levels of CFTR activity to rare CF mutations. Thus, mechanistic studies of CFTR folding, function and pharmacology inform the development of highly effective CFTR modulators. Elsevier 2020-03 /pmc/articles/PMC7052731/ /pubmed/31902693 http://dx.doi.org/10.1016/j.jcf.2019.12.009 Text en © 2020 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bose, Samuel J. Krainer, Georg Ng, Demi R.S. Schenkel, Mathias Shishido, Hideki Yoon, Jae Seok Haggie, Peter M. Schlierf, Michael Sheppard, David N. Skach, William R. Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR() |
title | Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR() |
title_full | Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR() |
title_fullStr | Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR() |
title_full_unstemmed | Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR() |
title_short | Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR() |
title_sort | towards next generation therapies for cystic fibrosis: folding, function and pharmacology of cftr() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052731/ https://www.ncbi.nlm.nih.gov/pubmed/31902693 http://dx.doi.org/10.1016/j.jcf.2019.12.009 |
work_keys_str_mv | AT bosesamuelj towardsnextgenerationtherapiesforcysticfibrosisfoldingfunctionandpharmacologyofcftr AT krainergeorg towardsnextgenerationtherapiesforcysticfibrosisfoldingfunctionandpharmacologyofcftr AT ngdemirs towardsnextgenerationtherapiesforcysticfibrosisfoldingfunctionandpharmacologyofcftr AT schenkelmathias towardsnextgenerationtherapiesforcysticfibrosisfoldingfunctionandpharmacologyofcftr AT shishidohideki towardsnextgenerationtherapiesforcysticfibrosisfoldingfunctionandpharmacologyofcftr AT yoonjaeseok towardsnextgenerationtherapiesforcysticfibrosisfoldingfunctionandpharmacologyofcftr AT haggiepeterm towardsnextgenerationtherapiesforcysticfibrosisfoldingfunctionandpharmacologyofcftr AT schlierfmichael towardsnextgenerationtherapiesforcysticfibrosisfoldingfunctionandpharmacologyofcftr AT shepparddavidn towardsnextgenerationtherapiesforcysticfibrosisfoldingfunctionandpharmacologyofcftr AT skachwilliamr towardsnextgenerationtherapiesforcysticfibrosisfoldingfunctionandpharmacologyofcftr |